News & Events

Linical Named Finalist for Citeline Japan Awards 2025 — Best Contract Research Organization

Written by Ali Cundari | Oct 14, 2025 12:00:00 PM

[Osaka, Japan, October , 2025] — We are proud to announce that Linical has been selected as a finalist in the Best Contract Research Organization (CRO) category for the Citeline Japan Awards 2025, recognizing our excellence in clinical development services, client relationships, and innovation in trial recruitment strategy.

About the Citeline Japan Awards

The Citeline Japan Awards honor innovation and achievement in the Japanese biopharma sector. Now in its 4th year, the 2025 Awards ceremony will be held in Tokyo on October 21, 2025, at the Palace Hotel. The Awards include multiple categories spanning drug development, biotech, licensing, and service providers across Japan and Asia. The Best Contract Research Organization award is specifically intended to spotlight CROs that provide full or specialized services in Japan or the Asia region, with an emphasis on service quality, client relationships, and innovative patient recruitment strategies.

What This Means for Linical

Being named a finalist is a major honor and a validation of the hard work we’ve invested in:

  • Maintaining high standards of clinical operations and regulatory compliance
  • Building strong, trust-based collaborations with our sponsors and partners
  • Innovating in patient recruitment and retention methods
  • Expanding and strengthening our presence throughout the Asia-Pacific region

This recognition affirms our commitment to delivering high-impact, high-quality clinical research services that help drive therapeutic development forward.

A Word from Leadership

“We are honored to be recognized by Citeline among such reputable peers in the CRO sector,” said Kazuhiro Hatano, President and CEO of Linical. “This finalist status reflects our team’s dedication to excellence, innovation, and partnership. As we celebrate our organization’s 20 Year Anniversary, we are proud of how Linical has grown from a Japanese-based CRO to a leading provider throughout the Asia-Pacific region and across the globe. We look forward to the awards ceremony and continuing to push boundaries in clinical research.”

What Happens Next & How You Can Support Us

The winners will be announced at the Tokyo ceremony on October 21, 2025. We will be attending and look forward to this momentous occasion.

We welcome our clients, partners, and stakeholders to celebrate with us. You can find more information on the awards website and check back for updates after the event.

Looking Forward 

Being a finalist demonstrates that Linical is among the most esteemed CROs in Asia. We remain committed to:

  • Deepening our presence and performance in Japanese and regional clinical trials
  • Strengthening client-centric innovation across all service lines
  • Continuously evolving and improving through feedback and emerging technologies

Stay tuned for updates after the awards, and thank you to everyone—our team, clients, and collaborators—who made this recognition possible.

Media Contacts: 

Alison Cundari

Senior Director, Marketing and Corporate Communications

acundari@linical.com